Industry News
New bio-secure facility to battle deadly diseases
A new world class bio-security facility has been opened in Geelong to research some of the most dangerous viruses and diseases known to science. [ + ]
Nanotechnology microscope boosts solar research
Queensland University of Technology is home to a powerful new ultrahigh vacuum and scanning probe microscope which is being used to develop efficient and low-cost plastic solar cells.
[ + ]CogState signs $2.6m contract for clinical trials technology
CogState (ASX:CGS) has signed a $2.6m contract with an international pharmaceutical company to use its cognition tests in a clinical trial of depression. [ + ]
Australia-China science and research fund open to applications
Australia-China research collaborations will benefit from an additional $18 million over the next three years with the opening of a dedicated Australia-China Science and Research Fund (ACSRF).
[ + ]Members invited to AusBiotech state Christmas events
With Christmas just around the corner, AusBiotech's CEO will be hosting state-based events around the country to celebrate the festive season and the year. [ + ]
Mesoblast stem cell trial shows reduced heart failure risk
Mesoblast's stem cell treatment for cardiovascular conditions is the first to have shown efficacy in treating the main causes of congestive heart failure. [ + ]
Doug Hilton receives accolade for grassroots outreach
WEHI head, Professor Doug Hilton, has received the 2011 Research Australia Leadership and Innovation Award in part for his agitation over the rumoured cuts to health and medical research. [ + ]
Starpharma raises $32m to fund VivaGel trial
Starpharma Holdings (ASX:SPL) has raised $32 million in a placement, and will seek a further $3 million in a SPP, to help fund clinical trials and new product development. [ + ]
Biotech and pharma driving HPLC market to US$4.1bn
The global HPLC systems and accessories market is forecast to reach US$4.1bn by 2017, according to a new report by Global Industry Analysts.
[ + ]Comment invited on R&D Tax Incentive Discussion Paper
AusIndustry has released a Discussion Paper on the R&D Tax Incentive in an effort to engage with a wide range of audiences to encourage an innovation culture and enable the development of strong guidance material for the new R&D Tax Incentive. [ + ]
Psivida plummets after FDA knockback
Share price drops by over 50% as FDA demands two more clinical trials for Psivida's flagship treatment, Iluvien, before it's approved for sale. [ + ]
Phosphagenics raises $3 million in oversubscribed SPP
Victoria-based Phospagenics (ASX:POH) has raised $3 million in a heavily oversubscribed share purchasing plan to fund the development of its targeted drug delivery products. [ + ]
Moles, eye colour and the genetics of skin cancer
A new study has identified that a gene variation associated with a greater number of moles and non-blue eye colour is linked to an increased risk of melanoma. [ + ]
Tackling breast cancer requires national coordination: report
A new report by the Economist Intelligence Unit says "fragmentation" of research, funding and treatment of breast cancer is hampering Australia's response to the disease. [ + ]
